ClearPoint Neuro Inc. (CLPT)
ClearPoint Neuro Inc. (CLPT) Stock Price, Analysis & Data
| Bid | 11.08 |
| Market Cap | 470.38M |
| Revenue (ttm) | 42.28M |
| Net Income (ttm) | -34.57M |
| Beta | 1.27 |
| EPS (ttm) | -1.18 |
| PE Ratio (ttm) | n/a |
| Forward PE | -13.93 |
| P/B (ttm) | 43.68 |
| P/S (ttm) | 11.13 |
| Earnings Date | Nov 5, 2026 |
| Ask | 19.39 |
| Volume | 311,891 |
| Avg. Volume (20D) | 749,630 |
| Open | 15.11 |
| Previous Close | 15.18 |
| Day's Range | 15.11 - 15.49 |
| 52-Week Range | 8.27 - 30.10 |
| Analyst | Strong Buy |
| Price Target | 25 (62.13%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CLPT
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand con...
Financial Performance
In 2025, ClearPoint Neuro's revenue was 36.97M, an increase of 17.78% compared to the previous year's 31.39M. Earnings were -25.54M, an increase of 35.03%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for CLPT stock is "Strong Buy". The 12-month stock price forecast is 25, which is upside of 62.13% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
